Advance articles
-
Accepted Manuscript
Editorial 17 April 2024
Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study
Roger J PackerNeuro-Oncology, noae079, https://doi.org/10.1093/neuonc/noae079Published: 17 April 2024 Section: Editorial -
Corrected Proof
Research Article 12 April 2024
NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma
Corina Anastasaki and othersNeuro-Oncology, noae054, https://doi.org/10.1093/neuonc/noae054Published: 12 April 2024 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 10 April 2024
Predicting the risk of neurocognitive decline after brain irradiation in adult patients with a primary brain tumor
Fariba Tohidinezhad and othersNeuro-Oncology, noae035, https://doi.org/10.1093/neuonc/noae035Published: 10 April 2024 Section: Basic and Translational Investigations -
Editor's Choice
Accepted Manuscript
Review Article 10 April 2024
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: a RANO review
Lakshmi Nayak and othersNeuro-Oncology, noae032, https://doi.org/10.1093/neuonc/noae032Published: 10 April 2024 Section: Review -
Corrected Proof
Editorial 9 April 2024
Locoregional delivery of chimeric antigen receptor-T cells: Breaking the spell in glioblastoma?
Marjolein Geurts and Matthias PreusserNeuro-Oncology, noae063, https://doi.org/10.1093/neuonc/noae063Published: 9 April 2024 Section: Breaking News Editorial -
Corrected Proof
Editorial 8 April 2024
Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight
Isabel Arrillaga-Romany and Julie J MillerNeuro-Oncology, noae051, https://doi.org/10.1093/neuonc/noae051Published: 8 April 2024 Section: Breaking News Editorial -
Accepted Manuscript
Research Article 6 April 2024
Secondary cerebro-cerebellar and intracerebellar dysfunction in cerebellar mutism syndrome
Samuel S McAfee and othersNeuro-Oncology, noae070, https://doi.org/10.1093/neuonc/noae070Published: 6 April 2024 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 6 April 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wildtype GBM
Elie Massaad and othersNeuro-Oncology, noae073, https://doi.org/10.1093/neuonc/noae073Published: 6 April 2024 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 5 April 2024
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment
Denise Obrecht-Sturm and othersNeuro-Oncology, noae071, https://doi.org/10.1093/neuonc/noae071Published: 5 April 2024 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 3 April 2024
Circulating extracellular vesicles as biomarker for diagnosis, prognosis and monitoring in glioblastoma patients
Franz L Ricklefs and othersNeuro-Oncology, noae068, https://doi.org/10.1093/neuonc/noae068Published: 3 April 2024 Section: Basic and Translational Investigations -
Letter 1 April 2024
Skull base chordoma and spinal chordoma exhibit consistency in terms of endoplasmic reticulum stress aspects
Hua-Qing Niu and othersNeuro-Oncology, noae050, https://doi.org/10.1093/neuonc/noae050Published: 1 April 2024 Section: Letter to the Editor -
Accepted Manuscript
Research Article 30 March 2024
[Ga68] DOTATATE PET/MRI-Guided Radiosurgical Treatment Planning and Response Assessment in Meningiomas
Jana Ivanidze and othersNeuro-Oncology, noae067, https://doi.org/10.1093/neuonc/noae067Published: 30 March 2024 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 30 March 2024
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
Daniel de la Nava and othersNeuro-Oncology, noae066, https://doi.org/10.1093/neuonc/noae066Published: 30 March 2024 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 30 March 2024
Super-enhancer-driven LIF promotes the mesenchymal transition in glioblastoma by activating ITGB2 signaling feedback in microglia
Han Xie and othersNeuro-Oncology, noae065, https://doi.org/10.1093/neuonc/noae065Published: 30 March 2024 Section: Basic and Translational Investigations -
Corrected Proof
Correction 23 March 2024
Corrigendum to: A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas
Neuro-Oncology, noae046, https://doi.org/10.1093/neuonc/noae046Published: 23 March 2024 Section: Corrigendum -
Corrected Proof
Editorial 22 March 2024
Targeting the cell cycle to enhance chemotherapy efficacy in glioblastoma
Matthew McCord and Pouya JamshidiNeuro-Oncology, noae062, https://doi.org/10.1093/neuonc/noae062Published: 22 March 2024 Section: Editorial -
Corrected Proof
Correction 20 March 2024
Corrigendum to: Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201
Neuro-Oncology, noae055, https://doi.org/10.1093/neuonc/noae055Published: 20 March 2024 Section: Corrigendum -
Accepted Manuscript
Research Article 20 March 2024
ARF4-mediated retrograde trafficking as a driver of chemoresistance in GBM
Shreya Budhiraja and othersNeuro-Oncology, noae059, https://doi.org/10.1093/neuonc/noae059Published: 20 March 2024 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 20 March 2024
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models
Andrea Álvarez-Vázquez and othersNeuro-Oncology, noae060, https://doi.org/10.1093/neuonc/noae060Published: 20 March 2024 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 20 March 2024
Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator
Alice Ryba and othersNeuro-Oncology, noae061, https://doi.org/10.1093/neuonc/noae061Published: 20 March 2024 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 19 March 2024
Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial
Patrick Roth and othersNeuro-Oncology, noae053, https://doi.org/10.1093/neuonc/noae053Published: 19 March 2024 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Editorial 15 March 2024
Can confocal laser endomicroscopy replace frozen section in diagnosis of brain tumors? A definite maybe
Mirna LechpammerNeuro-Oncology, noae042, https://doi.org/10.1093/neuonc/noae042Published: 15 March 2024 Section: Editorial -
Corrected Proof
Editorial 12 March 2024
Identification of transcriptomic signatures associated with glioblastoma recurrence
Sean E LawlerNeuro-Oncology, noae044, https://doi.org/10.1093/neuonc/noae044Published: 12 March 2024 Section: Breaking News Editorial -
Corrected Proof
Editorial 11 March 2024
Telomeres in glioma: Maintenance mechanisms to therapeutic potential
Nicholas O Stevers and Joseph F CostelloNeuro-Oncology, noae052, https://doi.org/10.1093/neuonc/noae052Published: 11 March 2024 Section: Editorial -
Accepted Manuscript
Research Article 11 March 2024
Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study
Alice Morin and othersNeuro-Oncology, noae045, https://doi.org/10.1093/neuonc/noae045Published: 11 March 2024 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Research Article 11 March 2024
Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma
Daniel C Moreira and othersNeuro-Oncology, noae048, https://doi.org/10.1093/neuonc/noae048Published: 11 March 2024 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Review Article 11 March 2024
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group
Norbert Galldiks and othersNeuro-Oncology, noae049, https://doi.org/10.1093/neuonc/noae049Published: 11 March 2024 Section: Review -
Corrected Proof
Review Article 9 March 2024
Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer
Seema Nagpal and othersNeuro-Oncology, noae041, https://doi.org/10.1093/neuonc/noae041Published: 9 March 2024 Section: Review -
Corrected Proof
Research Article 8 March 2024
Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing Hypoxia-inducible factor 1 alpha activity
Haidong Huang and othersNeuro-Oncology, noae036, https://doi.org/10.1093/neuonc/noae036Published: 8 March 2024 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 7 March 2024
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Emeline Tabouret and othersNeuro-Oncology, noae037, https://doi.org/10.1093/neuonc/noae037Published: 7 March 2024 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Review Article 6 March 2024
ACTION: A randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma
Isabel Arrillaga-Romany and othersNeuro-Oncology, noae031, https://doi.org/10.1093/neuonc/noae031Published: 6 March 2024 Section: H3 K27M-mutant Glioma Supplement Article -
Corrected Proof
Research Article 5 March 2024
HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma
Shixue Yang and othersNeuro-Oncology, noae040, https://doi.org/10.1093/neuonc/noae040Published: 5 March 2024 Section: Basic and Translational Investigations -
Corrected Proof
Editorial 5 March 2024
Harnessing generative AI for glioma diagnosis: A step forward in neuro-oncologic imaging
Matthew D Lee and Rajan JainNeuro-Oncology, noae043, https://doi.org/10.1093/neuonc/noae043Published: 5 March 2024 Section: Editorial -
Accepted Manuscript
Editorial 2 March 2024
Celebrating the 30th Anniversary of the European Association of Neuro-Oncology (EANO)
Matthias Preusser and othersNeuro-Oncology, noae039, https://doi.org/10.1093/neuonc/noae039Published: 2 March 2024 Section: Editorial -
Corrected Proof
Research Article 2 March 2024
Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities
Bo Li and othersNeuro-Oncology, noae038, https://doi.org/10.1093/neuonc/noae038Published: 2 March 2024 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 28 February 2024
Secreted clusterin inhibits tumorigenesis by modulating tumor cells and macrophages in human meningioma
Chao Ke and othersNeuro-Oncology, noae034, https://doi.org/10.1093/neuonc/noae034Published: 28 February 2024 Section: Basic and Translational Investigations -
Corrected Proof
Editorial 28 February 2024
Lymphatic endothelial-like cells in the glioblastoma tumor niche drive metabolic alterations that promote stem cell proliferation and survival
Reilly L Kidwell and Manish K AghiNeuro-Oncology, noae020, https://doi.org/10.1093/neuonc/noae020Published: 28 February 2024 Section: Breaking News Editorial -
Corrected Proof
Research Article 27 February 2024
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma
Sara Hiller-Vallina and othersNeuro-Oncology, noae033, https://doi.org/10.1093/neuonc/noae033Published: 27 February 2024 Section: Basic and Translational Investigations -
Accepted Manuscript
Review Article 24 February 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3K27M-mutant glioma
Yazmin Odia and othersNeuro-Oncology, noae001, https://doi.org/10.1093/neuonc/noae001Published: 24 February 2024 Section: H3 K27M-mutant Glioma Supplement Article -
Corrected Proof
Review Article 23 February 2024
Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?
Anthony R Sloan and othersNeuro-Oncology, noae011, https://doi.org/10.1093/neuonc/noae011Published: 23 February 2024 Section: Editor's Choice -
Corrected Proof
Correction 23 February 2024
Corrigendum to: Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group
Neuro-Oncology, noae030, https://doi.org/10.1093/neuonc/noae030Published: 23 February 2024 Section: Corrigendum -
Accepted Manuscript
Review Article 22 February 2024
Selective DRD2 Antagonist and ClpP Agonist ONC201 in a Recurrent Non-midline H3 K27M-mutant Glioma Cohort
Yazmin Odia and othersNeuro-Oncology, noae021, https://doi.org/10.1093/neuonc/noae021Published: 22 February 2024 Section: H3 K27M-mutant Glioma Supplement Article -
Corrected Proof
Correction 16 February 2024
Corrigendum to: Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group
Neuro-Oncology, noae024, https://doi.org/10.1093/neuonc/noae024Published: 16 February 2024 Section: Corrigendum -
Corrected Proof
Research Article 16 February 2024
Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study
Laura Rozenblum and othersNeuro-Oncology, noae029, https://doi.org/10.1093/neuonc/noae029Published: 16 February 2024 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Research Article 16 February 2024
Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide
Hong Sheng Cheng and othersNeuro-Oncology, noae028, https://doi.org/10.1093/neuonc/noae028Published: 16 February 2024 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 13 February 2024
Distinct uptake and elimination profiles for trastuzumab, human IgG, and biocytin-TMR in experimental HER2+ brain metastases of breast cancer
Vanesa L Silvestri and othersNeuro-Oncology, noae025, https://doi.org/10.1093/neuonc/noae025Published: 13 February 2024 Section: Basic and Translational Investigations -
Corrected Proof
Correction 12 February 2024
Correction to: Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression
Neuro-Oncology, noae022, https://doi.org/10.1093/neuonc/noae022Published: 12 February 2024 Section: Corrigendum -
Corrected Proof
Letter 10 February 2024
The greatest challenge for pediatric low-grade glioma
Daniel C Moreira and othersNeuro-Oncology, noae004, https://doi.org/10.1093/neuonc/noae004Published: 10 February 2024 Section: Letter to the Editor -
Corrected Proof
Letter 10 February 2024
Endoplasmic reticulum stress-related cancer-associated fibroblast confers adverse prognosis and therapeutic vulnerability in skull base chordoma
Mingxuan Li and othersNeuro-Oncology, noae007, https://doi.org/10.1093/neuonc/noae007Published: 10 February 2024 Section: Letter to the Editor -
Corrected Proof
Research Article 9 February 2024
Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis
Eric W Prince and othersNeuro-Oncology, noae015, https://doi.org/10.1093/neuonc/noae015Published: 9 February 2024 Section: Basic and Translational Investigations -
Corrected Proof
Expression of Concern 9 February 2024
Expression of Concern: microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis
Neuro-Oncology, noae026, https://doi.org/10.1093/neuonc/noae026Published: 9 February 2024 Section: EXPRESSION OF CONCERN -
Corrected Proof
Editorial 30 January 2024
TREM2 function in glioblastoma immune microenvironment: Can we distinguish reality from illusion?
Sourav Ghosh and Carla V RothlinNeuro-Oncology, noae019, https://doi.org/10.1093/neuonc/noae019Published: 30 January 2024 Section: Editorial -
Corrected Proof
Research Article 29 January 2024
Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress
Shaobo Wang and othersNeuro-Oncology, noae014, https://doi.org/10.1093/neuonc/noae014Published: 29 January 2024 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 29 January 2024
Glioblastoma and radiotherapy: A multicenter AI study for Survival Predictions from MRI (GRASP study)
Alysha Chelliah and othersNeuro-Oncology, noae017, https://doi.org/10.1093/neuonc/noae017Published: 29 January 2024 Section: Basic and Translational Investigations -
Corrected Proof
Review Article 29 January 2024
Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas
Matthew S Waitkus and othersNeuro-Oncology, noae016, https://doi.org/10.1093/neuonc/noae016Published: 29 January 2024 Section: Review -
Corrected Proof
Research Article 25 January 2024
Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes
Matthew Dankner and othersNeuro-Oncology, noae013, https://doi.org/10.1093/neuonc/noae013Published: 25 January 2024 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 22 January 2024
Generative AI in glioma: Ensuring diversity in training image phenotypes to improve diagnostic performance for IDH mutation prediction
Hye Hyeon Moon and othersNeuro-Oncology, noae012, https://doi.org/10.1093/neuonc/noae012Published: 22 January 2024 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Review Article 22 January 2024
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils
Mei-Yin C Polley and othersNeuro-Oncology, noae005, https://doi.org/10.1093/neuonc/noae005Published: 22 January 2024 Section: Review -
Corrected Proof
Research Article 19 January 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas
Kristyn Galbraith and othersNeuro-Oncology, noae009, https://doi.org/10.1093/neuonc/noae009Published: 19 January 2024 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 18 January 2024
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
Mekenzie M Peshoff and othersNeuro-Oncology, noad257, https://doi.org/10.1093/neuonc/noad257Published: 18 January 2024 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 18 January 2024
Fluorescein-stained confocal laser endomicroscopy versus conventional frozen section for intraoperative histopathological assessment of intracranial tumors
Arthur Wagner and othersNeuro-Oncology, noae006, https://doi.org/10.1093/neuonc/noae006Published: 18 January 2024 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Research Article 14 January 2024
Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide
Christina Maria Flies and othersNeuro-Oncology, noad247, https://doi.org/10.1093/neuonc/noad247Published: 14 January 2024 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Research Article 3 January 2024
Automated segmentation of ablated lesions using deep convolutional neural networks: A basis for response assessment following laser interstitial thermal therapy
Aden P Haskell-Mendoza and othersNeuro-Oncology, noad261, https://doi.org/10.1093/neuonc/noad261Published: 3 January 2024 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Research Article 30 December 2023
Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes
Matthias Dottermusch and othersNeuro-Oncology, noad265, https://doi.org/10.1093/neuonc/noad265Published: 30 December 2023 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 30 December 2023
Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation
Dan Liu and othersNeuro-Oncology, noad264, https://doi.org/10.1093/neuonc/noad264Published: 30 December 2023 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 28 December 2023
IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma
Joanna Obacz and othersNeuro-Oncology, noad256, https://doi.org/10.1093/neuonc/noad256Published: 28 December 2023 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 28 December 2023
Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities
Martha Foltyn-Dumitru and othersNeuro-Oncology, noad259, https://doi.org/10.1093/neuonc/noad259Published: 28 December 2023 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Research Article 23 December 2023
Developing a computable phenotype for glioblastoma
Sandra Yan and othersNeuro-Oncology, noad249, https://doi.org/10.1093/neuonc/noad249Published: 23 December 2023 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Research Article 22 December 2023
Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents
Fengchao Lang and othersNeuro-Oncology, noad252, https://doi.org/10.1093/neuonc/noad252Published: 22 December 2023 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 22 December 2023
The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAFV600E melanoma brain metastasis
Magali A de Sauvage and othersNeuro-Oncology, noad248, https://doi.org/10.1093/neuonc/noad248Published: 22 December 2023 Section: Basic and Translational Investigations -
Accepted Manuscript
Review Article 20 December 2023
Rational combination platform trial design for children and young adults with Diffuse Midline Glioma: a report from PNOC
Sabine Mueller and othersNeuro-Oncology, noad181, https://doi.org/10.1093/neuonc/noad181Published: 20 December 2023 Section: H3 K27M-mutant Glioma Supplement Article -
Accepted Manuscript
Review Article 18 December 2023
Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon
Matthew D Dun and othersNeuro-Oncology, noad245, https://doi.org/10.1093/neuonc/noad245Published: 18 December 2023 Section: H3 K27M-mutant Glioma Supplement Article -
Accepted Manuscript
Review Article 15 December 2023
H3 K27M-altered Glioma and Diffuse Intrinsic Pontine Glioma: Semi-systematic Review of Treatment Landscape and Future Directions
Martin van den Bent and othersNeuro-Oncology, noad220, https://doi.org/10.1093/neuonc/noad220Published: 15 December 2023 Section: H3 K27M-mutant Glioma Supplement Article -
Accepted Manuscript
Review Article 14 December 2023
Liquid Biopsy in H3K27M Diffuse Midline Glioma
Jina Patel and othersNeuro-Oncology, noad229, https://doi.org/10.1093/neuonc/noad229Published: 14 December 2023 Section: H3 K27M-mutant Glioma Supplement Article -
Corrected Proof
Research Article 12 December 2023
Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment
Dongwoo Kim and othersNeuro-Oncology, noad243, https://doi.org/10.1093/neuonc/noad243Published: 12 December 2023 Section: Basic and Translational Investigations -
Corrected Proof
Research Article 11 December 2023
Postoperative cerebellar mutism syndrome is an acquired autism-like network disturbance
Hrishikesh Suresh and othersNeuro-Oncology, noad230, https://doi.org/10.1093/neuonc/noad230Published: 11 December 2023 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Research Article 9 December 2023
Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001
Hua-Ren R Cherng and othersNeuro-Oncology, noad226, https://doi.org/10.1093/neuonc/noad226Published: 9 December 2023 Section: CLINICAL INVESTIGATIONS -
Corrected Proof
Research Article 9 December 2023
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance
Albert E Kim and othersNeuro-Oncology, noad236, https://doi.org/10.1093/neuonc/noad236Published: 9 December 2023 Section: Basic and Translational Investigations -
Corrected Proof
Correction 1 December 2023
Corrigendum to: Towards more Diversity in Neuro-oncology Leadership—the DivINe Initiative
Neuro-Oncology, noad213, https://doi.org/10.1093/neuonc/noad213Published: 1 December 2023 Section: Corrigendum -
Corrected Proof
Research Article 6 November 2023
TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas
Jiaying Zheng and othersNeuro-Oncology, noad214, https://doi.org/10.1093/neuonc/noad214Published: 6 November 2023 Section: Basic and Translational Investigations -
Accepted Manuscript
Review Article 11 October 2023
H3K27M Mutant Glioma: Disease Definition and Biological Underpinnings
Amanda M Saratsis and othersNeuro-Oncology, noad164, https://doi.org/10.1093/neuonc/noad164Published: 11 October 2023 Section: H3 K27M-mutant Glioma Supplement Article -
Accepted Manuscript
Review Article 17 August 2023
A review of the anti-tumor potential of current therapeutics targeting the mitochondrial protease ClpP in H3K27-altered, diffuse midline glioma
Evangeline R Jackson and othersNeuro-Oncology, noad144, https://doi.org/10.1093/neuonc/noad144Published: 17 August 2023 Section: H3 K27M-mutant Glioma Supplement Article